{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-027262","form_type":"8-K","ticker":"FATE","cik":"0001434316","company_name":"FATE THERAPEUTICS INC","filed_at":"2023-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.852026+00:00","generated_at":"2026-06-14T03:41:55.794633+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Fate Therapeutics reports 2023 annual meeting voting results","bullets":["Elected Class I directors Epstein, Mendlein, Jooss with >65.8M 'for' votes each; 10.2M broker non-votes.","Ratified Ernst & Young as auditor for FY2023: 85.5M for, 0.2M against, 1.2M abstentions.","Approved non-binding advisory vote on executive compensation: 73.7M for, 3.0M against, 0.1M abstentions.","Total shares present at meeting: 86.9M of 98.2M outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-027262","json":"https://secwatch.observer/filing/0000950170-23-027262.json","markdown":"https://secwatch.observer/filing/0000950170-23-027262.md","text":"https://secwatch.observer/filing/0000950170-23-027262.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434316/000095017023027262/0000950170-23-027262-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434316/000095017023027262/fate-20230606.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T03:41:55.794633+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"887352ea129f52b59db4617af83cbd8d8491a4b5","claim":"FATE THERAPEUTICS INC shareholders approved Non-binding advisory vote to approve compensation of named executive officers at the 2023-06-06 meeting.","evidence_excerpt":"Non-binding Advisory Vote on Compensation of Named Executive Officers. For Against Abstain Broker Non-Votes 73,720,442 2,955,503 61,938 10,211,752","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017023027262/0000950170-23-027262-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-06"}],"fact_type":"shareholder_vote"},{"claim_id":"a56acab6cb458468fa5ac98fdddd193d95605b92","claim":"FATE THERAPEUTICS INC shareholders approved Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm at the 2023-06-06 meeting.","evidence_excerpt":"Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. For Against Abstain Broker Non-Votes 85,534,350 197,464 1,217,821 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017023027262/0000950170-23-027262-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-06"}],"fact_type":"shareholder_vote"},{"claim_id":"d289bc0ce59d31ab51308a5a7fbc6bedf2e8c2d8","claim":"FATE THERAPEUTICS INC shareholders approved Election of three Class I Directors at the 2023-06-06 meeting.","evidence_excerpt":"Election of Class I Directors. Director Nominee For Withheld Broker Non-Votes Robert S. Epstein, M.D., M.S. 74,088,457 2,649,426 10,211,752 John D. Mendlein, Ph.D., J.D. 65,801,671 10,936,212 10,211,752 Karin Jooss, Ph.D. 74,481,093 2,256,790 10,211,752","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017023027262/0000950170-23-027262-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-06"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}